{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:28:02Z","timestamp":1770539282511,"version":"3.49.0"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,6,15]]},"DOI":"10.2169\/internalmedicine.4331-19","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T22:05:54Z","timestamp":1584569154000},"page":"1559-1563","source":"Crossref","is-referenced-by-count":31,"title":["Migratory Aortitis Associated with Granulocyte-colony-stimulating Factor"],"prefix":"10.2169","volume":"59","author":[{"given":"Tsuyoshi","family":"Shirai","sequence":"first","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroka","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Harigae","sequence":"additional","affiliation":[{"name":"Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bossone E, Pluchinotta FR, Andreas M, et al. Aortitis. Vascul Pharmacol 80: 1-10, 2016.","DOI":"10.1016\/j.vph.2015.11.084"},{"key":"2","unstructured":"2. Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65: 1-11, 2013."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Keser G, Aksu K. Diagnosis and differential diagnosis of large-vessel vasculitides. Rheumatol Int 39: 169-185, 2019.","DOI":"10.1007\/s00296-018-4157-3"},{"key":"4","unstructured":"4. Mutoh T, Ishii T, Shirai T, et al. Refractory Takayasu arteritis successfully treated with rituximab: case-based review. Rheumatol Int 39: 1989-1994, 2019."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Adiga GU, Elkadi D, Malik SK, Fitzpatrick JD, Madajewicz S. Abdominal aortitis after use of granulocyte colony-stimulating factor. Clin Drug Invest 29: 821-825, 2009.","DOI":"10.2165\/11530790-000000000-00000"},{"key":"6","unstructured":"6. Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31: 1409-1417, 2011."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Darie C, Boutalba S, Fichter P, et al. Aortitis after G-CSF injections. Rev Med Interne 25: 225-229, 2004 (in French, Abstract in English).","DOI":"10.1016\/j.revmed.2003.10.015"},{"key":"8","unstructured":"8. Lardieri A, McCulley L, Jones SC, Woronow D. Granulocyte colony-stimulating factors and aortitis: a rare adverse event. Am J Hematol 93: E333-E336, 2018."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Miller EB, Grosu R, Landau Z. Isolated abdominal aortitis following administration of granulocyte colony stimulating factor (G-CSF). Clin Rheumatol 35: 1655-1657, 2016.","DOI":"10.1007\/s10067-016-3253-6"},{"key":"10","unstructured":"10. Parodis I, Dani L, Notarnicola A, et al. G-CSF-induced aortitis: Two cases and review of the literature. Autoimmun Rev 18: 615-620, 2019."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sato Y, Kaji S, Ueda H, Tomii K. Thoracic aortitis and aortic dissection following pegfilgrastim administration. Eur J Cardio-Thorac 52: 993-994, 2017.","DOI":"10.1093\/ejcts\/ezx165"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mutoh T, Shirai T, Fujii H, Ishii T, Harigae H. Insufficient use of corticosteroids without immunosuppressants results in higher relapse in Takayasu arteritis. J Rheumatol 47: 255-263, 2020.","DOI":"10.3899\/jrheum.181219"},{"key":"13","unstructured":"13. Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K. Functional features of neutrophils induced by G-CSF and GM-CSF treatment: differential effects and clinical implications. Leukemia 11: 466-478, 1997."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kawakami T, Ohashi S, Kawa Y, et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of sweet syndrome and patients with active Beh\u00e7et disease - implication in neutrophil apoptosis dysfunction. Arch Dermatol 140: 570-574, 2004.","DOI":"10.1001\/archderm.140.5.570"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shirai T, Hanaoka R, Goto Y, et al. Takayasu arteritis coexisting with sclerosing osteomyelitis. Intern Med 57: 1929-1934, 2018.","DOI":"10.2169\/internalmedicine.0329-17"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ujiie H, Sawamura D, Yokota K, Nishie W, Shichinohe R, Shimizu H. Pyoderma gangrenosum associated with Takayasu's arteritis. Clin Exp Dermatol 29: 357-359, 2004.","DOI":"10.1111\/j.1365-2230.2004.01514.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Renauer P, Sawalha AH. The genetics of Takayasu arteritis. Presse Med 46: e179-e187, 2017.","DOI":"10.1016\/j.lpm.2016.11.031"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Umeda M, Ikenaga J, Koga T, et al. Giant cell arteritis which developed after the administration of granulocyte-colony stimulating factor for cyclic neutropenia. Intern Med 55: 2291-2294, 2016.","DOI":"10.2169\/internalmedicine.55.6704"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/12\/59_4331-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T03:30:19Z","timestamp":1592623819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/12\/59_4331-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4331-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}